Advertisement
During the early pandemic era

CDC: Decline Noted in ED Visits During Early Pandemic Period

0
42 percent decrease found in total number of U.S. ED visits; decreases largest for those ≤17 years, females
COVID-19 patients with hypertension have increased mortality risk

COVID-19 Mortality Higher for Those Not Taking Meds for Their HTN

0
Mortality similar with renin-angiotensin-aldosterone system inhibitor, non-RAAS inhibitor for HTN
A small number of nonhospitalized patients with COVID-19 who self-medicated with high-dose famotidine reported some relief of their symptoms

Some COVID-19 Outpatients Say Famotidine Eased Symptoms

0
Ten nonhospitalized patients who took famotidine reported some relief of COVID-19 symptoms
Francis Collins

NIH Head Fears Some Will Bypass a COVID-19 Vaccine

0
Name of campaign -- 'Operation Warp Speed' -- does not mean corners will be cut on safety
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of June 1 to 5

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
For patients with hip fracture

Pneumonia Risk Down With Nitrogen-Containing Bisphosphonates

0
Reductions in risk for pneumonia and pneumonia mortality seen among patients with hip fracture
Patients admitted to a New York City hospital with COVID-19 faced major morbidity and mortality

Acute Kidney Injury Common in COVID-19 Patients at NYC Hospital

0
Of patients admitted to ICU, 78.0 percent developed acute kidney injury, 35.2 percent needed dialysis
Pediatric patients with COVID-19 rarely have systemic inflammation

Systemic Inflammation Rare in Pediatric COVID-19 Patients

0
Level of interleukin 10 increased in moderate versus mild cases; no difference seen in IL6, TNFα, IFN-γ
For individuals with high- or moderate-risk exposure to COVID-19

Hydroxychloroquine No Use for COVID Postexposure Prophylaxis

0
Post-high-risk-exposure prophylaxis does not prevent illness compatible with COVID-19
Two premiere medical journals are questioning the validity of the data in two studies: one that showed the use of blood pressure drugs was safe in COVID-19 patients and another that showed the antimalarial drug hydroxychloroquine was dangerous

COVID-19 Drug Studies Questioned

0
Journals issue 'expressions of concern' over two recent studies of medications and their effect on COVID-19 patients